Axel Nierhaus to Sepsis
This is a "connection" page, showing publications Axel Nierhaus has written about Sepsis.
Connection Strength
0.780
-
Predicting the requirement for renal replacement therapy in intensive care patients with sepsis. Crit Care. 2018 08 20; 22(1):201.
Score: 0.219
-
Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFa response: A diagnostic tool for immunosuppression? PLoS One. 2017; 12(8):e0182427.
Score: 0.204
-
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101). Biomolecules. 2020 08 11; 10(8).
Score: 0.063
-
Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial. Trials. 2019 Mar 04; 20(1):156.
Score: 0.057
-
Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival. Crit Care. 2018 09 19; 22(1):216.
Score: 0.055
-
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial. Crit Care. 2018 Mar 21; 22(1):79.
Score: 0.053
-
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study. Crit Care. 2018 01 30; 22(1):25.
Score: 0.053
-
Markers of nitric oxide are associated with sepsis severity: an observational study. Crit Care. 2017 Jul 15; 21(1):189.
Score: 0.051
-
[Lactic acidosis - update 2018]. Dtsch Med Wochenschr. 2018 08; 143(15):1082-1085.
Score: 0.014
-
Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis. J Antimicrob Chemother. 2017 05 01; 72(5):1433-1440.
Score: 0.013